90
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Spread of Cryptococcus gattii into Pacific Northwest Region of the United States

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This organism should be recognized as an emerging pathogen in the United States.

          Abstract

          Cryptococcus gattii has emerged as a human and animal pathogen in the Pacific Northwest. First recognized on Vancouver Island, British Columbia, Canada, it now involves mainland British Columbia, and Washington and Oregon in the United States. In Canada, the incidence of disease has been one of the highest worldwide. In the United States, lack of cryptococcal species identification and case surveillance limit our knowledge of C. gattii epidemiology. Infections in the Pacific Northwest are caused by multiple genotypes, but the major strain is genetically novel and may have emerged recently in association with unique mating or environmental changes. C. gattii disease affects immunocompromised and immunocompetent persons, causing substantial illness and death. Successful management requires an aggressive medical and surgical approach and consideration of potentially variable antifungal drug susceptibilities. We summarize the study results of a group of investigators and review current knowledge with the goal of increasing awareness and highlighting areas where further knowledge is required.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

          A prospective population-based study was conducted in Australia and New Zealand during 1994-1997 to elucidate the epidemiology of cryptococcosis due to Cryptococcus neoformans var. neoformans (CNVN) and C. neoformans var. gattii (CNVG) and to relate clinical manifestations to host immune status and cryptococcal variety. The mean annual incidence per 10(6) population was 6.6 in Australia and 2.2 in New Zealand. Of 312 episodes, CNVN caused 265 (85%; 98% of the episodes in immunocompromised hosts) and CNVG caused 47 (15%; 44% of the episodes in immunocompetent hosts). The incidence of AIDS-associated cases in Australia declined annually (P<.001). Aborigines in rural or semirural locations (P<.001) and immunocompetent males (P<.001) were at increased risk of CNVG infection. Cryptococcomas in lung or brain were more common in immunocompetent hosts (P< or =.03) in whom there was an association only between lung cryptococcomas and CNVG. An AIDS-associated genetic profile of CNVN serotype A was confirmed by random amplification of polymorphic DNA analysis. Resistance to antifungal drugs was uncommon. The epidemiology of CNVN infection has changed substantially. Clinical manifestations of disease are influenced more strongly by host immune status than by cryptococcal variety.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans.

            Amplified fragment length polymorphism (AFLP) genotyping of isolates of the pathogenic fungus Cryptococcus neoformans suggested a considerable genetic divergence between the varieties C. neoformans var. neoformans and C. neoformans var. grubii on the one hand versus C. neoformans var. gattii on the other. This divergence is supported by additional phenotypic, biochemical, clinical and molecular differences. Therefore, the authors propose the existence of two species, C. neoformans (Sanfelice) Vuillemin and C. bacillisporus Kwon-Chung, which differ in geographical distribution, serotypes and ecological origin. Within each species three AFLP genotypes occur, which differ in geographical distribution and serotypes. Differences in ecological origin (AIDS patients, non-AIDS patients, animals or the environment) were found to be statistically not significant. In C. neoformans as well as in C. bacillisporus one of the genotypes represented a hybrid. The occurrence of hybridization has consequences for the reproductive biology of the species, as new genotypes with altered virulence or susceptibility to antifungal drugs may arise through the exchange of genetic material.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

              A simple new agar medium containing L-canavanine, glycine, and bromthymol blue was found to give a clearer and more accurate distinction between serotype A or D (Cryptococcus neoformans var. neoformans) and serotype B or C (C. neoformans var. gattii) than creatinine-dextrose-bromthymol blue or glycine-cycloheximide-phenol red media. Among 143 isolates of serotype A or D and 70 isolates of serotype B or C, the new medium correlated completely with the serotype, whereas nearly 11% of these isolates gave discrepant reactions with creatinine-dextrose-bromthymol blue and glycine-cycloheximide-phenol red media.
                Bookmark

                Author and article information

                Journal
                Emerg Infect Dis
                EID
                Emerging Infectious Diseases
                Centers for Disease Control and Prevention
                1080-6040
                1080-6059
                August 2009
                : 15
                : 8
                : 1185-1191
                Affiliations
                [1]Johns Hopkins University School of Medicine, Baltimore, Maryland, USA (K. Datta, K.A. Marr)
                [2]University of British Columbia, Vancouver, British Columbia, Canada (K.H. Bartlett)
                [3]Washington State Department of Health, Shoreline, Washington, USA (R. Baer)
                [4]Duke University Medical Center, Durham, North Carolina, USA (E. Byrnes, J. Heitman)
                [5]British Columbia Centre for Disease Control, Vancouver (E. Galanis, L. Hoang, L. MacDougall, M.G. Morshed)
                [6]British Columbia Ministry of Agriculture and Lands, Abbotsford, British Columbia, Canada (M.J. Leslie)
                [7]Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.S. Magill)
                Author notes
                Address for correspondence: Kieren A. Marr, Division of Infectious Diseases, Johns Hopkins University School of Medicine, 720 Rutland Ave, Ross Research Bldg, Rm 1064, Baltimore, MD 21205, USA; email: kmarr4@ 123456jhmi.edu
                Article
                08-1384
                10.3201/eid1508.081384
                2815957
                19757550
                b8391d3f-74a0-4bdf-a8a8-00465f03ae2d
                History
                Categories
                Synopsis

                Infectious disease & Microbiology
                vancouver island,synopsis,canada,fungi,united states,cryptococcosis,pacific northwest,cryptococcus gattii

                Comments

                Comment on this article